Impact of Bortezomib On the Treatment of Antibody Mediated Rejection Following Kidney Transplant.

被引:0
|
作者
Kassis, Y. [1 ]
Shetty, A. [1 ]
Flechner, S. [1 ]
Chiesa-Vottero, A. [2 ]
Fatica, R. [1 ]
机构
[1] Cleveland Clin Fdn, Glickman Urol & Kidney Inst, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Cleveland, OH 44195 USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
B869
引用
收藏
页码:512 / 512
页数:1
相关论文
共 50 条
  • [21] Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients: A Single-Center Experience With a Bortezomib-Based Regimen
    Nigos, Janice G.
    Arora, Swati
    Nath, Parineesha
    Hussain, Sabiha M.
    Marcus, Richard J.
    Ko, Tina Y.
    Sureshkumar, Kalathil K.
    [J]. EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2012, 10 (06) : 609 - 613
  • [22] Bortezomib in the treatment of antibody-mediated rejection in pediatric kidney transplant recipients: A multicenter Midwest Pediatric Nephrology Consortium study
    Kizilbash, Sarah
    Claes, Donna
    Ashoor, Isa
    Chen, Ashton
    Jandeska, Sara
    Matar, Raed Bou
    Misurac, Jason
    Sherbotie, Joseph
    Twombley, Katherine
    Verghese, Priya
    [J]. PEDIATRIC TRANSPLANTATION, 2017, 21 (03)
  • [23] THE ROLE OF BORTEZOMIB IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS WITH ANTIBODY MEDIATED REJECTION
    Pearl, M.
    Ettenger, R.
    Chambers, E. Tsai
    Nayak, A.
    [J]. PEDIATRIC TRANSPLANTATION, 2015, 19 : 89 - 89
  • [24] Bortezomib for antibody-mediated rejection in a young lung transplant recipient
    Hayes, Don, Jr.
    Nicholson, Kerri L.
    Baker, Peter B.
    [J]. PEDIATRIC TRANSPLANTATION, 2016, 20 (01) : 178 - 179
  • [25] Donor Specific Antibody Responsiveness as a Predictor of Graft Function Following Bortezomib Treatment of Antibody Mediated Rejection
    Howell, M. H.
    Macaluso, M.
    Saggi, B. H.
    Killackey, M.
    Paramesh, A.
    Zhang, R.
    Alper, B.
    McGee, J.
    Lukitsch, I.
    Heneghan, J.
    Sullivan, K.
    Khan, E.
    Slakey, D.
    Buell, J. F.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 410 - 411
  • [26] BORTEZOMIB USE FOR ANTIBODY-MEDIATED REJECTION IN PEDIATRIC HEART TRANSPLANT
    Chen, Dong-Feng
    Jaquiss, Robert D. B.
    Lodge, Andrew J.
    Carboni, Michael P.
    [J]. HUMAN IMMUNOLOGY, 2012, 73 : 104 - 104
  • [27] The Role of Bortezomib in Pediatric Renal Transplant Recipients With Antibody Mediated Rejection
    Nayak, A.
    Tsai, E.
    Ettenger, R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 499 - 499
  • [28] Mechanism and treatment for chronic antibody-mediated rejection in kidney transplant recipients
    Sasaki, Hajime
    Tanabe, Tatsu
    Tsuji, Takahiro
    Hotta, Kiyohiko
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (08) : 624 - 633
  • [29] Costs of Treatment of Acute Antibody-Mediated Rejection in Kidney Transplant Recipients
    Labus, Anna L.
    Mucha, Krzysztof
    Kulesza, Andrzej
    Fliszkiewicz, Magda
    Paczek, Leszek
    Niemczyk, Mariusz
    [J]. TRANSPLANTATION PROCEEDINGS, 2022, 54 (04) : 968 - 971
  • [30] Prevention of antibody-mediated kidney transplant rejection
    Morath, Christian
    Opelz, Gerhard
    Zeier, Martin
    Suesal, Caner
    [J]. TRANSPLANT INTERNATIONAL, 2012, 25 (06) : 633 - 645